Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s footer software/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.”
    Difference
    0.0%
    Check dated 2026-04-24T17:13:51.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2 supersedes v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-04-17T14:07:30.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    IgA glomerulonephritis was added as a listed condition, aligning with IgA nephropathy. This text update does not modify study design, eligibility criteria, or measured outcomes.
    Difference
    0.0%
    Check dated 2026-04-03T05:59:09.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:50:43.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Page revision history updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:15:52.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive study details appear to have changed, To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:45:55.000Z thumbnail image

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.